Ms. Birgit Stattin Norinder is an Independent Director at AddLife AB, an Independent Director at Hansa Medical AB and an Independent Director at Nicox SA.
She is on the Board of Directors at AddLife AB, Hansa Medical AB, Nicox SA, Jettesta AB, Navigation Dynamics AB, Wingfirm Pharma AB and WntResearch AB.
Ms. Norinder was previously employed as an Independent Director by Karo Pharma AB, a President & Chief Executive Officer by deCODE genetics, Inc., an Independent Non-Executive Director by Sarossa Capital Plc, a Chairman & Chief Executive Officer by Prolifix Ltd., a Vice President-Infection Research & Development by Astra Research Centre AB, a Director-International Regulatory Affairs by Glaxo Group Research Ltd., a Chairman & Chief Executive Officer by Lauras AS, a Vice President-Infection Research & Development by Parke-Davis AB, a Board member by Partners för Utvecklingsinvesteringar inom Life Sciences AB, a Principal by Pfizer Inc., and a Senior VP-Worldwide Product Development by Pharmacia & Upjohn, Inc.
She also served on the board at EXINI Diagnostics AB, Biolipox AB, Artimplant AB, InDex Pharmaceuticals Holding AB, MiniDoc AB, NeoDynamics AB, Photocure ASA and Probi AB.
She received her graduate degree from the University of Uppsala.